Wepon Pharmaceuticals Group Co. Ltd.

The study used a single-center, open, sequential single-dose design. To evaluate the pharmacokinetics and dose-exposure relationship of huperzine A injection

This study will conduct a single-center clinical trial to explore the initial therapeutic effect of ginkgo biloba dropping pills, huperzine A injection and median nerve electrical stimulation in patients with cognitive impairment.

以万邦德制药集团有限公司的头孢克洛颗粒为受试制剂；并以苏州西克罗制药有限公司持证的头孢克洛干混悬剂（商品名：希刻劳®）为参比制剂，进行人体相对生物利用度和生物等效性评价。